ERBB2 and breast carcinoma: Among the CTCs from patients with breast cancers clinically defined as HER2 positive from analyses of their primary tumours (FISH+ and/or IHC 3+ by local testing, n=24), 72% of all captured cells had a HER2 gene copy number ⩾4.